Deep Phenotyping And AlphaFold
Marc Bickle discusses how Deep Phenotyping and AlphaFold are transforming early-stage drug discovery. Learn about cutting-edge technologies that enhance precision in oncology and neurodegenerative research, offering new insights and accelerating the development of personalized therapies through advanced AI-driven methods and high-content imaging.
Guardians of Health
Thomas Müller, a distinguished scientist with over 30 years' experience in ion channel research, talks about his journey from studying biology in Heidelberg and Glasgow to leading high-throughput screening at Bayer, where he's been at the forefront of scientific innovation. In this enlightening session, Thomas shares his remarkable journey and delves into the fascinating world of ion channels.